Geoffrey O'Neill
Corporate Officer/Principal chez The Trustees of Columbia University in The City of New York
Postes actifs de Geoffrey O'Neill
Sociétés | Poste | Début | Fin |
---|---|---|---|
The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - | - |
Historique de carrière de Geoffrey O'Neill
Anciens postes connus de Geoffrey O'Neill
Sociétés | Poste | Début | Fin |
---|---|---|---|
BMXP Holdings, Inc. | President | - | 11/06/2008 |
Frezer, Inc.
Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | President | 02/05/2005 | 22/02/2007 |
Bio-Matrix Scientific Group, Inc. /Old/ | President | - | 28/08/2006 |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
President | 3 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Bio-Matrix Scientific Group, Inc. /Old/ | Health Technology |
BMXP Holdings, Inc. | Health Technology |
Frezer, Inc.
Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | Health Technology |
- Bourse
- Insiders
- Geoffrey O'Neill
- Expérience